James Investment Research Inc Bristol Myers Squibb CO Transaction History

James Investment Research Inc

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 25, 2023	BUY	$65.71 - $74.53 $2,628 - $2,981	40 Added 11.43%	390 $27,000
Q3 2022 Oct 31, 2022	SELL	$0.13 - $76.84 $19 - $11,526	-150 Reduced 30.0%	350 $25,000
Q1 2022 Apr 22, 2022	SELL	$61.48 - $73.72 $12,296 - $14,744	-200 Reduced 28.57%	500 $37,000
Q4 2021 Jan 28, 2022	BUY	$53.63 - $62.52 $5,363 - $6,252	100 Added 16.67%	700 $44,000
Q4 2019 Jan 24, 2020	SELL	$49.21 - $64.19 $10,776 - $14,057	-219 Reduced 26.74%	600 $39,000
Q1 2019 Apr 26, 2019	BUY	$45.12 - $53.8 $9,881 - $11,782	219 Added 36.5%	819 $39,000
Q3 2017 Oct 13, 2017	BUY	$55.23 - $63.74 $33,138 - $38,244	600	600 $38,000

2,428

1.5B

29.7M

32.2M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of James Investment Research Inc, based on Form 13F filings with the SEC.

Stay updated on James Investment Research Inc with notifications on news.